Fundraising Fox

Paul Hung

Investor

Venture Partner – Life Sciences at Endurance28

San Francisco Bay Area

About

Paul Hung is a scientist-entrepreneur trained in Bioengineering at UC Berkeley with more than two decades of experience in life sciences. He co-founded CellASIC, which developed the ONIX microfluidic live-cell imaging platform and was acquired by MilliporeSigma (Merck KGaA), and later founded COMBiNATi, a digital PCR company acquired by Thermo Fisher Scientific in 2021. After running Thermo Fisher's global digital PCR business, he became CEO of Taudia, developing a blood-based biomarker platform for Alzheimer's and brain-health diagnostics.

Invests in

BiotechDigital HealthHealthtech

Experience

  1. TaudiaChief Executive Officercurrent2025 — presentSan Carlos, California, United States
  2. Live and LearnFree agentcurrent2024 — present
  3. Thermo Fisher ScientificSenior Director R&D (Emerging Technology)2024San Francisco Bay Area
  4. Thermo Fisher ScientificSenior Director and General Manager, Digital PCR2021 — 2024Palo Alto, California, United States
  5. CombinatiChief Executive Officer2016 — 2021Palo Alto, California, United States
  6. EMD MilliporeSenior R&D Manager2012 — 2016Hayward CA
  7. CellASIC CorporationChief Technology Offier2005 — 2012Hayward, CA

Education

  1. University of California, BerkeleyPhD, Electrical Engineering2000 — 2005
  2. National Taiwan UniversityBachelor's degree, Electrical engineering1993 — 1997

Skills & more

Microfluidics30Product Development25MEMS7Lifesciences2Matlab3Life Sciences23Medical Devices3Biotechnology12Cross-functional Team Leadership4Product Management2Biomedical Engineering3Cell Culture6
+12 moreCommercializationR&DCellMolecular BiologyCell BiologyLaboratoryTechnology TransferManufacturingLeadershipResearchProject ManagementResearch and Development (R&D)

Languages English · Mandarin

From Paul's professional profile.

Same school

Shared employers

Colleagues at Endurance28